| Dr James R Hill, MD | |
|
1420 W Midway Blvd, Broomfield, CO 80020-2090 | |
| (303) 466-1866 | |
| (303) 466-4081 |
| Full Name | Dr James R Hill |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 1420 W Midway Blvd, Broomfield, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194748046 | NPI | - | NPPES |
| 01212257 | Medicaid | CO | |
| H131936 | Other | CO | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 21225 (Colorado) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr James R Hill, MD 1596 Wildwood Ln, Boulder, CO 80305-6225 Ph: (303) 494-5916 | Dr James R Hill, MD 1420 W Midway Blvd, Broomfield, CO 80020-2090 Ph: (303) 466-1866 |
News Archive
Anadys Pharmaceuticals, Inc. announced today that it has initiated the planned Phase IIb study of ANA598 in combination with pegylated interferon and ribavirin. The protocol for the study has been cleared by the United States Food and Drug Administration and Health Canada.
HemCon Medical Technologies, Inc., announced today that the U.S. Court of Appeals for the Federal Circuit granted HemCon's motion to stay the injunction and final judgment (including the damages award) obtained against it in a patent infringement case brought by Marine Polymer Technologies, Inc.
"Snoring, sleep apnoea, and obesity-related respiratory difficulties are fairly common disorders that affect a large proportion of the population," according to Poul Jennum, Professor of Clinical Neurophysiology at the Center for Healthy Ageing at the University of Copenhagen Faculty of Health Sciences. He is head of the Danish Centre for Sleep Medicine, Glostrup Hospital, which treats patients from all over the country.
The clot-inhibiting drug apixaban (trade name: Eliquis) has been approved in Germany since November 2012 for the prevention of embolism and stroke in adults with non-valvular atrial fibrillation.
Avila Therapeutics™, Inc., a biotechnology company developing targeted covalent drugs that treat diseases through protein silencing, presented results of preclinical studies on two of its Hepatitis C Virus protease inhibitors, AVL-181 and AVL-192. These inhibitors, due to their unique mechanism of action with superior selectivity and potency, have potential as best-in-class, pan-genotype HCV therapeutics.
› Verified 5 days ago
Matthew Aaron Liebentritt, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 12169 Sheridan Blvd, Broomfield, CO 80020 Phone: 303-603-9400 Fax: 303-603-9420 | |
Pamela Rollins Abrams, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 433 Summit Blvd, Unit 201, Broomfield, CO 80021 Phone: 303-673-9090 Fax: 303-673-9195 | |
Megan Perez Viquez, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 14300 Orchard Pkwy, Broomfield, CO 80023 Phone: 720-627-0000 | |
Daniel Goodeill, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 340 E 1st Ave Ste 101, Broomfield, CO 80020 Phone: 303-544-3800 Fax: 303-544-3810 | |
Michael Dewey, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7403 Church Ranch Blvd Unit 107, Broomfield, CO 80021 Phone: 720-848-9400 | |
Timothy M Lewan, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 12169 Sheridan Blvd, Broomfield, CO 80020 Phone: 303-603-9400 Fax: 303-603-9420 |